U.S. regulators Friday expanded the use of Merck’s cervical cancer vaccine to adults up to age 45.
FDA expands use of cervical cancer vaccine up to age 45
U.S. regulators Friday expanded the use of Merck’s cervical cancer vaccine to adults up to age 45.